세계의 세포유전학 시장 : 제품별, 기술별, 용도별, 최종사용자별 - 기회 분석과 산업 예측(2024-2035년)

Cytogenetics Market By Product, By Technique, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035

US $ 4,425 ￦ 6,091,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,204,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

세포유전학 시장은 2023년에 28억 940만 달러로 평가되며 2024년부터 2035년까지 연평균 11.7%로 성장하여 2035년에는 106억 2,705만 달러에 달할 것으로 예상됩니다.

세포유전학은 DNA를 포함한 세포 내 구조인 염색체를 연구하는 유전학의 한 분야입니다. 염색체의 수, 구조, 거동을 분석하여 유전, 질병, 생물학적 기능에서 염색체의 역할을 이해합니다. 핵형 분석, 형광 in situ hybridization(FISH), 비교 유전체 하이브리드화(CGH) 등의 세포유전학 기술을 통해 결실, 중복, 전좌, 이수성 등의 염색체 이상을 확인할 수 있습니다. 이러한 이상은 다양한 유전성 질환, 암, 선천성 질환과 관련이 있습니다. 세포의 염색체 구성을 조사함으로써 세포유전학은 산전진단, 암 연구, 유전상담, 맞춤의료에서 중요한 역할을 하고 있습니다. 이 분야는 고전 유전학과 현대 분자생물학을 연결하여 염색체 수준의 변화가 개인의 건강과 연구 개발에 어떤 영향을 미치는지에 대한 인사이트를 제공하며, 임상과 연구 모두에서 필수적인 도구가 되고 있습니다.

세포유전학 시장의 성장을 촉진하는 주요 요인으로는 전 세계적으로 유전성 질환과 암의 유병률 증가가 세포유전학 검사 및 진단에 대한 수요를 촉진하고 있습니다. 다운증후군과 같은 유전질환과 다양한 종류의 암이 보편화됨에 따라 정확하고 조기 발견할 수 있는 방법의 필요성이 크게 증가하고 있습니다. 핵형 분석, 형광 in situ hybridization(FISH), 염색체 마이크로어레이 분석(CMA)과 같은 세포유전학 기술은 이러한 질병과 관련된 염색체 이상을 식별하는 데 필수적이며, 시장 성장을 촉진하고 있습니다.

그러나 장비 및 전문 지식을 포함한 세포유전학 기술과 관련된 높은 비용, 특히 중저소득 국가에서는 특히 높은 비용으로 인해 고급 진단 도구에 대한 접근이 제한되어 시장 성장에 걸림돌이 되고 있습니다. 또한, 세포유전학적 시술이 복잡하기 때문에 숙련된 전문가와 전문 교육이 필요한데, 특정 지역에서는 이러한 전문 인력이 부족하여 시장 성장을 더욱 제한할 수 있습니다. 한편, 환자 개개인의 유전자 프로파일에 맞는 치료를 위해 첨단 유전자 검사에 크게 의존하는 맞춤의료에 대한 수요 증가와 신흥국에서의 높은 성장 잠재력은 시장 확대의 기회를 창출하고 있습니다.

세포유전학 시장은 제품, 기술, 용도, 최종사용자, 지역으로 분류됩니다. 제품별로는 소모품, 기기, 소프트웨어 및 서비스로 구분됩니다. 소모품 부문은 다시 검사 키트 및 시약, 배지, 프로브, 기타로 분류됩니다. 배지 부문은 다시 혈청 배지 및 기타로 세분화됩니다. 방법별로 시장은 비교 유전체 하이브리드화, FISH(Fluorescent In Situ Hybridization), 핵형 분석, 기타로 분류됩니다. 핵형 분류는 다시 산전검사, 암, 기타로 분류됩니다. 산전검사 분야는 소모품, 장비, 소프트웨어 및 서비스로 분류됩니다. 암 분야는 다시 검사 키트와 시약 및 배지를 포함한 소모품으로 분류됩니다. 기타는 검사 키트와 시약 및 배지를 포함한 소모품으로 분류됩니다.

용도별로는 유전자 질환, 암, 맞춤의료, 기타로 분류됩니다. 최종사용자별로는 임상/연구소, 제약/바이오테크놀러지 기업, 학술연구기관, 기타로 분류됩니다. 지역별로는 북미(미국, 캐나다, 멕시코), 유럽(독일, 프랑스, 영국, 이탈리아, 스페인, 기타), 아시아태평양(일본, 중국, 인도, 호주, 한국, 기타), 라틴아메리카, 중동 및 아프리카(브라질, 남아프리카, 사우디아라비아, 기타), 기타 지역으로 조사 조사됩니다.

이해관계자를 위한 주요 이점

• 이 보고서는 2023년부터 2035년까지 세포유전학 시장 분석의 시장 부문, 현재 동향, 추정 및 동향, 역학에 대한 정량적 분석을 제공하고, 세포유전학 시장의 유력한 기회를 식별합니다.
• 시장 촉진요인, 시장 억제요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.
• Porter's Five Forces 분석은 이해 관계자가 이익 중심의 비즈니스 결정을 내리고 공급자와 구매자 네트워크를 강화할 수 있도록 구매자와 공급자의 잠재력을 강조합니다.
• 세포 유전학 시장 세분화에 대한 상세한 분석은 시장 기회를 결정하는 데 도움이됩니다.
• 각 지역의 주요 국가는 세계 시장에 대한 수익 기여도에 따라 매핑되어 있습니다.
• 시장 기업의 포지셔닝은 벤치마킹을 용이하게 하고, 시장 기업의 현재 위치를 명확하게 이해할 수 있습니다.
• 이 보고서에는 지역별 및 세계 세포유전학 시장 동향, 주요 기업, 시장 부문, 응용 분야, 시장 성장 전략에 대한 분석이 포함되어 있습니다.

본 보고서에서 가능한 커스터마이징

• 규제 가이드라인
• 고객의 관심사에 따른 기업 프로파일 추가
• 기업 개요 확장 목록
• 과거 시장 데이터

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

• 시장 정의와 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
    • 유전성 질환 유병률 증가
    • 맞춤형 의료에 대한 인식과 도입 증가
    • 기술의 진보
  • 성장 억제요인
    • 기기나 시술의 높은 비용
  • 기회
    • 연구개발에 대한 주력 상승
    • 신흥 국가의 높은 성장 가능성

제4장 세포유전학 시장 : 제품별

• 개요
• 소모품
• 기기
• 소프트웨어와 서비스

제5장 세포유전학 시장 : 기술별

• 개요
• CGH(Comparative Genome Hybridization)
• FISH(Fluorescent In Situ Hybridization)
• 핵형 분석
• 기타

제6장 세포유전학 시장 : 용도별

• 개요
• 유전질환
• 암
• 맞춤형 의료
• 기타

제7장 세포유전학 시장 : 최종사용자별

• 개요
• 임상 연구기관
• 제약·바이오테크놀러지 기업
• 학술연구기관
• 기타

제8장 세포유전학 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카, 중동 및 아프리카
  • 브라질
  • 남아프리카공화국
  • 사우디아라비아
  • 기타

제9장 경쟁 상황

• 소개
• 주요 성공 전략
• 주요 10개사 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제10장 기업 개요

• PAN-Biotech
• Precipio, Inc.
• Applied Spectral Imaging
• Capricorn Scientific
• Thermo Fisher Scientific Inc.
• AddLife

ksm

영문 목차

영문목차

The cytogenetics market was valued at $2,809.40 million in 2023 and is estimated to reach $10,627.05 million by 2035, exhibiting a CAGR of 11.7% from 2024 to 2035.

Cytogenetics is a branch of genetics focused on the study of chromosomes, the structures within cells that contain DNA. It involves analyzing the number, structure, and behavior of chromosomes to understand their role in heredity, disease, and biological function. Techniques in cytogenetics, such as karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH), allow scientists to identify chromosomal abnormalities, such as deletions, duplications, translocations, and aneuploidies. These abnormalities are linked to various genetic disorders, cancers, and congenital conditions. By examining the chromosomal makeup of cells, cytogenetics plays a crucial role in prenatal diagnosis, cancer research, genetic counseling, and personalized medicine. The field bridges classical genetics with modern molecular biology, offering insights into how changes at the chromosomal level can affect an individual's health and development, making it an essential tool in both clinical and research settings.

The major factors that drive the growth of cytogenetics market include the rise in prevalence of genetic disorders and cancer globally which fuels demand for cytogenetic testing and diagnostics. As genetic conditions such as Down syndrome, and various types of cancer become more prevalent, the need for accurate and early detection methods has grown significantly. Cytogenetic techniques, including karyotyping, fluorescence in situ hybridization (FISH), and chromosomal microarray analysis (CMA), are essential for identifying chromosomal abnormalities associated with these conditions, thereby driving market growth.

However, the high cost associated with cytogenetic technologies, including equipment, and specialized expertise can be prohibitive, particularly in low- and middle-income countries, limiting access to advanced diagnostic tools and limiting the market growth. In addition, the complexity of cytogenetic procedures requires skilled professionals and specialized training, which can be scarce in certain regions, further constraining market growth. On the other hand, increase in demand for personalized medicine, which relies heavily on advanced genetic testing to tailor treatments to individual patients' genetic profiles and high growth potential in emerging countries create an opportunity for market expansion.

Cytogenetics market is categorized into product, technique, application, end user, and region. On the basis of the product, it is segmented into consumable, instrument, and software & service. The consumables segment is further classified into testing kits and reagents, media, probes, and others. Media segment further includes serum media and others. On the basis of technique, the market is segmented into comparative genome hybridization, fluorescence in situ hybridization, karyotyping, and others. The karyotyping segment further categorized into prenatal testing, cancer, and others. Prenatal testing segment categorized into consumable, instrument, and software & services. Cancer segment further categorized into consumables which includes testing kits and reagents and media. Others segment also categorized into consumables which includes testing kits and reagents and media.

On the basis of application, it is segmented into genetic disorders, cancer, personalized medicine, and others. On the basis of end user, the market is classified into clinical and research laboratory, pharmaceutical and biotechnology company, academic research institute, and others. Region-wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA).

The major companies profiled in the report include PAN-Biotech, Precipio, Inc., Applied Spectral Imaging, Capricorn Scientific, AddLife, and Thermo Fisher Scientific Inc. The key players operating in the market have adopted partnership, joint venture, collaboration, and agreement as their key strategy to expand their product portfolio. For instance, in January 2024, Barco and Applied Spectral Imaging (ASI), a world leader in advanced biomedical imaging with a comprehensive product portfolio for karyotyping, H&E, IHC and FISH imaging and analysis, announced a new commercial partnership to offer best-in-class digital solutions for pathology laboratories

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cytogenetics market analysis from 2023 to 2035 to identify the prevailing cytogenetics market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the cytogenetics market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global cytogenetics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Expanded list for Company Profiles
• Historic market data

Key Market Segments

By Product

• Consumable
  • Type
  • Testing kits
  • Media

◦ Type

• Probes
• Others
• Instrument
• Software and service

By Technique

• Comparitive genome hybridization
• Fluorescence in situ hybridization
• Karyotyping
  • Type
  • Prenatal Testing

◦ Type

• Cancer

◦ Consumables

• Others

◦ Consumable

• Others

By Application

• Genetic disorder
• Cancer
• Personalized medicine
• Others

By End User

• Clinical and research laboratory
  • Type
  • Cancer Research
  • Clinical Diagnostics Labs
  • Others
• Pharmaceutical and biotechnology company
• Academic Research Institute
• Other

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa,
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• AddLife
• Applied Spectral Imaging
• PAN-Biotech
• Precipio, Inc.
• Capricorn Scientific
• Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Moderate bargaining power of suppliers
  • 3.3.2. Moderate threat of new entrants
  • 3.3.3. Moderate threat of substitutes
  • 3.3.4. Moderate intensity of rivalry
  • 3.3.5. Moderate bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Increase in prevalence of genetic disorders
    • 3.4.1.2. Increase in awareness and adoption of personalized medicine
    • 3.4.1.3. Advancement in technology
  • 3.4.2. Restraints
    • 3.4.2.1. High costs of equipment and procedures
  • 3.4.3. Opportunities
    • 3.4.3.1. Increase in focus on R&D
    • 3.4.3.2. High growth potential in emerging countries

CHAPTER 4: CYTOGENETICS MARKET, BY PRODUCT

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Consumable
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
  • 4.2.4. Consumable Cytogenetics Market by Type
    • 4.2.4.1. Media Cytogenetics Market by Type
• 4.3. Instrument
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Software and service
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country

CHAPTER 5: CYTOGENETICS MARKET, BY TECHNIQUE

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Comparitive genome hybridization
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Fluorescence in situ hybridization
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Karyotyping
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
  • 5.4.4. Karyotyping Cytogenetics Market by Type
    • 5.4.4.1. Prenatal Testing Cytogenetics Market by Type
    • 5.4.4.1.1. Consumables Cytogenetics Market by Type
    • 5.4.4.2. Cancer Cytogenetics Market by Consumables
    • 5.4.4.2.1. Media Cytogenetics Market by Type
    • 5.4.4.3. Others Cytogenetics Market by Consumable
    • 5.4.4.3.1. Media Cytogenetics Market by Type
• 5.5. Others
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country

CHAPTER 6: CYTOGENETICS MARKET, BY APPLICATION

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Genetic disorder
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Cancer
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Personalized medicine
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country
• 6.5. Others
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by region
  • 6.5.3. Market share analysis by country

CHAPTER 7: CYTOGENETICS MARKET, BY END USER

• 7.1. Overview
  • 7.1.1. Market size and forecast
• 7.2. Clinical and research laboratory
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by region
  • 7.2.3. Market share analysis by country
  • 7.2.4. Clinical and research laboratory Cytogenetics Market by Type
• 7.3. Pharmaceutical and biotechnology company
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by region
  • 7.3.3. Market share analysis by country
• 7.4. Academic Research Institute
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by region
  • 7.4.3. Market share analysis by country
• 7.5. Other
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by region
  • 7.5.3. Market share analysis by country

CHAPTER 8: CYTOGENETICS MARKET, BY REGION

• 8.1. Overview
  • 8.1.1. Market size and forecast By Region
• 8.2. North America
  • 8.2.1. Key market trends, growth factors and opportunities
  • 8.2.2. Market size and forecast, by Product
  • 8.2.3. Market size and forecast, by Technique
  • 8.2.4. Market size and forecast, by Application
  • 8.2.5. Market size and forecast, by End User
  • 8.2.6. Market size and forecast, by country
    • 8.2.6.1. U.S.
    • 8.2.6.1.1. Market size and forecast, by Product
    • 8.2.6.1.2. Market size and forecast, by Technique
    • 8.2.6.1.3. Market size and forecast, by Application
    • 8.2.6.1.4. Market size and forecast, by End User
    • 8.2.6.2. Canada
    • 8.2.6.2.1. Market size and forecast, by Product
    • 8.2.6.2.2. Market size and forecast, by Technique
    • 8.2.6.2.3. Market size and forecast, by Application
    • 8.2.6.2.4. Market size and forecast, by End User
    • 8.2.6.3. Mexico
    • 8.2.6.3.1. Market size and forecast, by Product
    • 8.2.6.3.2. Market size and forecast, by Technique
    • 8.2.6.3.3. Market size and forecast, by Application
    • 8.2.6.3.4. Market size and forecast, by End User
• 8.3. Europe
  • 8.3.1. Key market trends, growth factors and opportunities
  • 8.3.2. Market size and forecast, by Product
  • 8.3.3. Market size and forecast, by Technique
  • 8.3.4. Market size and forecast, by Application
  • 8.3.5. Market size and forecast, by End User
  • 8.3.6. Market size and forecast, by country
    • 8.3.6.1. Germany
    • 8.3.6.1.1. Market size and forecast, by Product
    • 8.3.6.1.2. Market size and forecast, by Technique
    • 8.3.6.1.3. Market size and forecast, by Application
    • 8.3.6.1.4. Market size and forecast, by End User
    • 8.3.6.2. France
    • 8.3.6.2.1. Market size and forecast, by Product
    • 8.3.6.2.2. Market size and forecast, by Technique
    • 8.3.6.2.3. Market size and forecast, by Application
    • 8.3.6.2.4. Market size and forecast, by End User
    • 8.3.6.3. UK
    • 8.3.6.3.1. Market size and forecast, by Product
    • 8.3.6.3.2. Market size and forecast, by Technique
    • 8.3.6.3.3. Market size and forecast, by Application
    • 8.3.6.3.4. Market size and forecast, by End User
    • 8.3.6.4. Italy
    • 8.3.6.4.1. Market size and forecast, by Product
    • 8.3.6.4.2. Market size and forecast, by Technique
    • 8.3.6.4.3. Market size and forecast, by Application
    • 8.3.6.4.4. Market size and forecast, by End User
    • 8.3.6.5. Spain
    • 8.3.6.5.1. Market size and forecast, by Product
    • 8.3.6.5.2. Market size and forecast, by Technique
    • 8.3.6.5.3. Market size and forecast, by Application
    • 8.3.6.5.4. Market size and forecast, by End User
    • 8.3.6.6. Rest of Europe
    • 8.3.6.6.1. Market size and forecast, by Product
    • 8.3.6.6.2. Market size and forecast, by Technique
    • 8.3.6.6.3. Market size and forecast, by Application
    • 8.3.6.6.4. Market size and forecast, by End User
• 8.4. Asia-Pacific
  • 8.4.1. Key market trends, growth factors and opportunities
  • 8.4.2. Market size and forecast, by Product
  • 8.4.3. Market size and forecast, by Technique
  • 8.4.4. Market size and forecast, by Application
  • 8.4.5. Market size and forecast, by End User
  • 8.4.6. Market size and forecast, by country
    • 8.4.6.1. Japan
    • 8.4.6.1.1. Market size and forecast, by Product
    • 8.4.6.1.2. Market size and forecast, by Technique
    • 8.4.6.1.3. Market size and forecast, by Application
    • 8.4.6.1.4. Market size and forecast, by End User
    • 8.4.6.2. China
    • 8.4.6.2.1. Market size and forecast, by Product
    • 8.4.6.2.2. Market size and forecast, by Technique
    • 8.4.6.2.3. Market size and forecast, by Application
    • 8.4.6.2.4. Market size and forecast, by End User
    • 8.4.6.3. India
    • 8.4.6.3.1. Market size and forecast, by Product
    • 8.4.6.3.2. Market size and forecast, by Technique
    • 8.4.6.3.3. Market size and forecast, by Application
    • 8.4.6.3.4. Market size and forecast, by End User
    • 8.4.6.4. Australia
    • 8.4.6.4.1. Market size and forecast, by Product
    • 8.4.6.4.2. Market size and forecast, by Technique
    • 8.4.6.4.3. Market size and forecast, by Application
    • 8.4.6.4.4. Market size and forecast, by End User
    • 8.4.6.5. South Korea
    • 8.4.6.5.1. Market size and forecast, by Product
    • 8.4.6.5.2. Market size and forecast, by Technique
    • 8.4.6.5.3. Market size and forecast, by Application
    • 8.4.6.5.4. Market size and forecast, by End User
    • 8.4.6.6. Rest of Asia-Pacific
    • 8.4.6.6.1. Market size and forecast, by Product
    • 8.4.6.6.2. Market size and forecast, by Technique
    • 8.4.6.6.3. Market size and forecast, by Application
    • 8.4.6.6.4. Market size and forecast, by End User
• 8.5. LAMEA
  • 8.5.1. Key market trends, growth factors and opportunities
  • 8.5.2. Market size and forecast, by Product
  • 8.5.3. Market size and forecast, by Technique
  • 8.5.4. Market size and forecast, by Application
  • 8.5.5. Market size and forecast, by End User
  • 8.5.6. Market size and forecast, by country
    • 8.5.6.1. Brazil
    • 8.5.6.1.1. Market size and forecast, by Product
    • 8.5.6.1.2. Market size and forecast, by Technique
    • 8.5.6.1.3. Market size and forecast, by Application
    • 8.5.6.1.4. Market size and forecast, by End User
    • 8.5.6.2. South Africa,
    • 8.5.6.2.1. Market size and forecast, by Product
    • 8.5.6.2.2. Market size and forecast, by Technique
    • 8.5.6.2.3. Market size and forecast, by Application
    • 8.5.6.2.4. Market size and forecast, by End User
    • 8.5.6.3. Saudi Arabia
    • 8.5.6.3.1. Market size and forecast, by Product
    • 8.5.6.3.2. Market size and forecast, by Technique
    • 8.5.6.3.3. Market size and forecast, by Application
    • 8.5.6.3.4. Market size and forecast, by End User
    • 8.5.6.4. Rest of LAMEA
    • 8.5.6.4.1. Market size and forecast, by Product
    • 8.5.6.4.2. Market size and forecast, by Technique
    • 8.5.6.4.3. Market size and forecast, by Application
    • 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

• 9.1. Introduction
• 9.2. Top winning strategies
• 9.3. Product mapping of top 10 player
• 9.4. Competitive dashboard
• 9.5. Competitive heatmap
• 9.6. Top player positioning, 2023

CHAPTER 10: COMPANY PROFILES

• 10.1. PAN-Biotech
  • 10.1.1. Company overview
  • 10.1.2. Key executives
  • 10.1.3. Company snapshot
  • 10.1.4. Operating business segments
  • 10.1.5. Product portfolio
• 10.2. Precipio, Inc.
  • 10.2.1. Company overview
  • 10.2.2. Key executives
  • 10.2.3. Company snapshot
  • 10.2.4. Operating business segments
  • 10.2.5. Product portfolio
  • 10.2.6. Business performance
  • 10.2.7. Key strategic moves and developments
• 10.3. Applied Spectral Imaging
  • 10.3.1. Company overview
  • 10.3.2. Key executives
  • 10.3.3. Company snapshot
  • 10.3.4. Operating business segments
  • 10.3.5. Product portfolio
  • 10.3.6. Key strategic moves and developments
• 10.4. Capricorn Scientific
  • 10.4.1. Company overview
  • 10.4.2. Key executives
  • 10.4.3. Company snapshot
  • 10.4.4. Operating business segments
  • 10.4.5. Product portfolio
• 10.5. Thermo Fisher Scientific Inc.
  • 10.5.1. Company overview
  • 10.5.2. Key executives
  • 10.5.3. Company snapshot
  • 10.5.4. Operating business segments
  • 10.5.5. Product portfolio
  • 10.5.6. Business performance
  • 10.5.7. Key strategic moves and developments
• 10.6. AddLife
  • 10.6.1. Company overview
  • 10.6.2. Key executives
  • 10.6.3. Company snapshot
  • 10.6.4. Operating business segments
  • 10.6.5. Product portfolio
  • 10.6.6. Business performance

관련자료